Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Símbolo de cotizaciónNUWE
Nombre de la empresaNuwellis Inc
Fecha de salida a bolsaFeb 16, 2012
Fundada en2002
Director ejecutivoErb (John L)
Número de empleados38
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 16
Dirección12988 Valley View Rd
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal55344
Teléfono19523454200
Sitio Webhttps://www.nuwellis.com/
Símbolo de cotizaciónNUWE
Fecha de salida a bolsaFeb 16, 2012
Fundada en2002
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos